Allan J Pantuck


Ontology type: schema:Person     


Person Info

NAME

Allan J

SURNAME

Pantuck

Publications in SciGraph latest 50 shown

  • 2019-12-20 The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-10-24 Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma in ABDOMINAL RADIOLOGY
  • 2019-10-17 Molecular Biology and Genetics of Renal Cell Carcinoma in RENAL CANCER
  • 2019-10-03 The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort in BMC MEDICINE
  • 2019-09-13 Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients in WORLD JOURNAL OF UROLOGY
  • 2019-03-07 The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas in ABDOMINAL RADIOLOGY
  • 2019-02-21 Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2018-09-28 Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines in WORLD JOURNAL OF UROLOGY
  • 2018-06-27 Clear cell renal cell carcinoma: identifying PTEN expression on multiphasic MDCT in ABDOMINAL RADIOLOGY
  • 2018-06-01 Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art in WORLD JOURNAL OF UROLOGY
  • 2018-05-11 Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy in WORLD JOURNAL OF UROLOGY
  • 2018-03-08 Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression in ABDOMINAL RADIOLOGY
  • 2018-01-03 Trends in urinary diversion after radical cystectomy for urothelial carcinoma in WORLD JOURNAL OF UROLOGY
  • 2017-10-27 Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance in ABDOMINAL RADIOLOGY
  • 2017-09-21 Efficacy of percutaneous radiofrequency ablation may vary with clear cell renal cell cancer histologic subtype in ABDOMINAL RADIOLOGY
  • 2017-04-25 A review of pomegranate in prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2017-03-07 Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT in ABDOMINAL RADIOLOGY
  • 2016-11-15 Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-08-13 Clear cell renal cell carcinoma: identifying the gain of chromosome 12 on multiphasic MDCT in ABDOMINAL RADIOLOGY
  • 2016-06-17 Clear cell renal cell carcinoma: identifying the gain of chromosome 20 on multiphasic MDCT in ABDOMINAL RADIOLOGY
  • 2016 Collecting Duct Carcinoma and Renal Medullary Carcinoma in THE KIDNEY
  • 2015-07-14 A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2014-04-10 The contemporary role on surgery in the management of renal masses in WORLD JOURNAL OF UROLOGY
  • 2014-04-04 The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation in WORLD JOURNAL OF UROLOGY
  • 2014-02-27 Clear cell renal cell carcinoma: multiphasic MDCT enhancement can predict the loss of chromosome 8p in ABDOMINAL RADIOLOGY
  • 2012-09-26 IGFBP-3 Nuclear Localization Predicts Human Prostate Cancer Recurrence in DISCOVER ONCOLOGY
  • 2012-08-07 Etiology of Renal Cell Carcinoma: Incidence, Demographics, and Environmental Factors in RENAL CELL CARCINOMA
  • 2011-04-19 A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2008-10-18 MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure in INVESTIGATIONAL NEW DRUGS
  • 2008-01 Genomics and proteomics in renal cell carcinoma: Diagnosis, prognosis, and treatment selection in CURRENT UROLOGY REPORTS
  • 2008 Comment rationaliser le suivi après traitement local? in LE CANCER DU REIN
  • 2007-07-27 A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer in BMC CANCER
  • 2007-01-12 Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neck in LASERS IN MEDICAL SCIENCE
  • 2007-01 Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (Sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy in CURRENT UROLOGY REPORTS
  • 2006-11-07 Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis in BRITISH JOURNAL OF CANCER
  • 2006-10 Determining the prognosis of patients with renal cell carcinoma: is it time for a re-evaluation? in NATURE REVIEWS UROLOGY
  • 2006-02-15 Long-term outcomes of the surgical management of renal cell carcinoma in WORLD JOURNAL OF UROLOGY
  • 2006-02 Phase-ii study of pomegranate juice for men with prostate cancer and increasing psa in CURRENT UROLOGY REPORTS
  • 2005-04 G250: A carbonic anhydrase IX monoclonal antibody in CURRENT ONCOLOGY REPORTS
  • 2003 Basic Biology and Clinical Behavior of Renal Cell Carcinoma in KIDNEY CANCER
  • 2003-01 Monoclonal antibodies for the treatment of advanced cancer in CURRENT UROLOGY REPORTS
  • 2002-02 A randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2/interferon in CURRENT UROLOGY REPORTS
  • 2002-02 Minimally invasive ablative approaches in the treatment of renal cell carcinoma in CURRENT UROLOGY REPORTS
  • 2001-02 Molecular-based therapies for renal cell carcinoma in CURRENT UROLOGY REPORTS
  • 2001-02 Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancer in CURRENT UROLOGY REPORTS
  • 2001-02 Dendritic cell-based immunotherapy of renal cell carcinoma in CURRENT UROLOGY REPORTS
  • 2000-12-01 Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2000-04 Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions in WORLD JOURNAL OF UROLOGY
  • 1996-11 Occult bilateral ectopic vaginal ureters causing urinary incontinence: diagnosis by computed tomography in ABDOMINAL RADIOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.19006.3e", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.22937.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411388.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.420228.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5611.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4691.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.13339.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14848.31", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5590.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10420.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412659.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413990.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.278247.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10417.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.430387.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.23856.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417768.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413083.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5603.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416122.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.241116.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411154.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410368.8", 
            "type": "Organization"
          }
        ], 
        "familyName": "Pantuck", 
        "givenName": "Allan J", 
        "id": "sg:person.01365327543.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365327543.53"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-08-04T17:38", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/person/person_806.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01365327543.53'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01365327543.53'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01365327543.53'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01365327543.53'


     

    This table displays all metadata directly associated to this object as RDF triples.

    62 TRIPLES      10 PREDICATES      34 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01365327543.53 schema:affiliation Nb8634ca1bae14f14bcf9f05545904dc7
    2 grid-institutes:grid.10417.33
    3 grid-institutes:grid.10420.37
    4 grid-institutes:grid.13339.3b
    5 grid-institutes:grid.14848.31
    6 grid-institutes:grid.22937.3d
    7 grid-institutes:grid.23856.3a
    8 grid-institutes:grid.240145.6
    9 grid-institutes:grid.241116.1
    10 grid-institutes:grid.278247.c
    11 grid-institutes:grid.410368.8
    12 grid-institutes:grid.411154.4
    13 grid-institutes:grid.411388.7
    14 grid-institutes:grid.412659.d
    15 grid-institutes:grid.413083.d
    16 grid-institutes:grid.413990.6
    17 grid-institutes:grid.416122.2
    18 grid-institutes:grid.417768.b
    19 grid-institutes:grid.420228.e
    20 grid-institutes:grid.430387.b
    21 grid-institutes:grid.4691.a
    22 grid-institutes:grid.5590.9
    23 grid-institutes:grid.5603.0
    24 grid-institutes:grid.5611.3
    25 schema:familyName Pantuck
    26 schema:givenName Allan J
    27 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365327543.53
    28 schema:sdDatePublished 2022-08-04T17:38
    29 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    30 schema:sdPublisher N58ecd33262f54e9ea48ebc3a7c4d0c10
    31 sgo:license sg:explorer/license/
    32 sgo:sdDataset persons
    33 rdf:type schema:Person
    34 N58ecd33262f54e9ea48ebc3a7c4d0c10 schema:name Springer Nature - SN SciGraph project
    35 rdf:type schema:Organization
    36 Nb8634ca1bae14f14bcf9f05545904dc7 schema:affiliation grid-institutes:grid.19006.3e
    37 sgo:isCurrent true
    38 rdf:type schema:OrganizationRole
    39 grid-institutes:grid.10417.33 schema:Organization
    40 grid-institutes:grid.10420.37 schema:Organization
    41 grid-institutes:grid.13339.3b schema:Organization
    42 grid-institutes:grid.14848.31 schema:Organization
    43 grid-institutes:grid.19006.3e schema:Organization
    44 grid-institutes:grid.22937.3d schema:Organization
    45 grid-institutes:grid.23856.3a schema:Organization
    46 grid-institutes:grid.240145.6 schema:Organization
    47 grid-institutes:grid.241116.1 schema:Organization
    48 grid-institutes:grid.278247.c schema:Organization
    49 grid-institutes:grid.410368.8 schema:Organization
    50 grid-institutes:grid.411154.4 schema:Organization
    51 grid-institutes:grid.411388.7 schema:Organization
    52 grid-institutes:grid.412659.d schema:Organization
    53 grid-institutes:grid.413083.d schema:Organization
    54 grid-institutes:grid.413990.6 schema:Organization
    55 grid-institutes:grid.416122.2 schema:Organization
    56 grid-institutes:grid.417768.b schema:Organization
    57 grid-institutes:grid.420228.e schema:Organization
    58 grid-institutes:grid.430387.b schema:Organization
    59 grid-institutes:grid.4691.a schema:Organization
    60 grid-institutes:grid.5590.9 schema:Organization
    61 grid-institutes:grid.5603.0 schema:Organization
    62 grid-institutes:grid.5611.3 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...